Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Clinical trial NCT06666153 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06666153
Sponsor: West China Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome PTLDs

Start date: 2024-10-01
Primary completion: 2025-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.